β-Hydoxy-β-methylbutyrate supplementation affects Walker 256 tumor-bearing rats in a time-dependent manner

Clinical Nutrition

Volumn 26, Issue 1, 2007, Pages 117-122

  Caperuto, Érico Chagas ^a   Tomatieli, Ronaldo Vagner ^a   Colquhoun, Alison ^a   Seelaender, Marília Cerqueira Leite ^a   Costa Rosa, Luis Fernando Bicudo Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

hydoxy methylbutyrate; Cancer cachexia; Intermediary metabolism; Walker 256 tumor

Indexed keywords

3 HYDROXY 3 METHYLBUTYRIC ACID; ALIPHATIC DICARBOXYLIC ACID; CORTICOSTERONE; FAT; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCOGEN; INSULIN; LACTIC ACID; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CANCER SURVIVAL; CARCASS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIET SUPPLEMENTATION; FAT CONTENT; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; MALE; METABOLIC PARAMETERS; NONHUMAN; PROTEIN CONTENT; RAT; SURVIVAL TIME; TIME; WALKER CARCINOMA;

3-HYDROXYBUTYRIC ACID; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; CACHEXIA; CARCINOMA 256, WALKER; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLYCOGEN; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LIVER GLYCOGEN; MALE; PROTEINS; RATS; RATS, WISTAR; SURVIVAL RATE; TIME FACTORS;

EID: 33846658434     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.05.007     Document Type: Article

References (33)

1. Brown J.K. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncol Nurs Forum 29 3 (2002) 517-532
2. Argiles J.M., Moore-Carrasco R., and Busquets S. Lopez-Soriano FJ Catabolic mediators as targets for cancer cachexia. Drug Discov Today 8 18 (2003) 838-844
3. Fearon K.C., and Moses A.G. Cancer cachexia. Int J Cardiol 85 1 (2002) 73-81
4. Barber M.D., Ross J.A., and Fearon K.C. Cancer cachexia. Surg Oncol 8 3 (1999) 133-141
5. von Haehling S., Genth-Zots S., Anker S.D., and Volk H.D. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol 85 1 (2002) 173-183
6. Klein S., and Koretz R.L. Nutrition support in patients with cancer: what do the data really show?. Nutr Clin Pract 9 3 (1994) 91-100
7. Fearon K.C.H., and Carter D.C. Cancer cachexia. Ann Surg 208 (1988) 1-4
8. Argiles J.M., and Lopez-Soriano F.J. Why do cancer cells have such a high glycolytic rate?. Med Hypotheses 32 2 (1990) 151-155
9. Argiles J.M., Alvarez B., and Lopez-Soriano F.J. The metabolic basis of cancer cachexia. Med Res Rev 17 5 (1997) 477-498
10. Llovera M., Garcia-Martinez C., Agell N., Marzabal M., Lopez-Soriano F.J., and Argiles J.M. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett 338 3 (1994) 311-318
11. Nissen S.L., and Abumrad N.N. Nutritional role of the leucine metabolite β-hydroxy β-methylbutyrate (HMβ). J Nutr Biochem 8 (1997) 300-311
12. Nissen S., Sharp R., Rathmacher J.A., et al. The effect of leucine metabolite β-hydroxy β-methylbutyrate (HMβ) on muscle metabolism during resistance-exercise training. J Appl Physiol 81 (1996) 2095-2104
13. Peluso G., Nicolai R., Reda E., Benatti P., Barbarisi A., and Calvani M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 182 3 (2000) 339-350
14. Kurth A.H., Wang C., Hayes W.C., and Shea M. The evaluation of a rat model for the analysis of densitometric and biomechanical properties of tumor-induced osteolysis. J Orthop Res 19 2 (2001) 200-205
15. Piffar P.M., Fernandez R., Tchaikovski O., et al. Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor bearing rats. Cancer Lett 201 2 (2003) 139-148
16. Heymsfield S.B., and McManus C.B. Tissue components of weight loss in cancer patients. A new method of study and preliminary observations. Cancer 55 1 Suppl (1985) 238-249
17. Sjorgreen B., Nordenskjold T., Holmgren H., and Wollestron J. Beitrag zur kentnis des lebenrhythmik. Pflugers Arch Ges Phys (1938) 240-247
18. Hassid W.Z., and Abrahams S. Chemical procedures for analyses of polisaccharides. Methods Enzymol 3 (1957) 34-51
19. Lowry O.H., Rosebruogh N.J., Farr A.L., and Randall R.J. Proteins mesurements with Folin phenol reagent. J Biol Chem 193 (1951) 265-275
20. Stansbie D. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J 160 (1976) 413-416
21. Windmueller H.G., and Spaeth A.E. Uptake and metabolism of plasma glutamine by small intestine. J Biol Chem 249 (1974) 5070-5079
22. Engle P.C., and Jones J.B. Causes and elimination of erratic blanks in enzymatic metabolite assays involving the use of NAD in alkaline hydrazine buffers: improved conditions for the assay of l-glutamate, l-lactate and others metabolites. Anal Biochem 88 (1978) 475-484
23. Bernt E., and Bergmeyer H.U. l-glutamate UV-assay with glutamate dehydrogenase and NAD. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1974), Academic Press, London 1704-1708
24. Oba-Shinjo S.M., Berto A.G.A., Passeroti C.C., et al. Walker 256 tumor growth causes marked changes of glutamine metabolism in rat small intestine. Cell Biochem Funct 20 (2002) 107-113
25. He Y.C., Wang Y.H., Cao J., Chen J.W., Pan D.Y., and Zhou Y.K. Effect of complex amino acid imbalance on growth of tumor in tumor-bearing rats. World J Gastroenterol 9 12 (2003) 2772-2775
26. Smith H.J., Wyke S.M., and Tisdale M.J. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by β-hydroxy-β-methylbutirate. Cancer Res 64 1 (2004) 8731-8735
27. May P.E., Barber A., D'Olimpio J.T., Hourihane A., and Abumrad N.N. Reversal of cancer-relater wasting using oral supplementation with a combination of HMβ, arginine and glutamine. Am J Surg 183 (2002) 471-479
28. Seelaender M.C., Nascimento C.M., Curi R., and Williams J.F. Studies on the lipid metabolism of Walker 256 tumour-bearing rats during the development of cancer cachexia. Biochem Mol Biol Int 39 5 (1996) 1037-1047
29. Warburg O. Metabolism of tumors (1930), Arnold Constable, London
30. Vicentino C., Constantin J., Stecanella L.A., Bracht A., and Yamamoto N.S. Glucose and glycogen catabolism in perfused livers of Walker 256 tumor bearing rats and the response to hormones. Pathophysiology 8 (2002) 175-182
31. Mazzoccoli G., Carughi S., De Cata A., La Viola M., and Vendemiale G. Melatonin and cortisol serum levels in lung cancer patients at different stages of disease. Med Sci Monit 11 6 (2005) 284-288 [Epub ahead of print]
32. Russell S.T., and Tisdale M.J. The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer 92 5 (2005) 876-881
33. Lima M.M.R., de Mello M.A.R., and Curi R. Walker 256 tumor growth causes marked changes of glutamine metabolism in rat small intestine. Cell biochem. Funct 20 (2002) 107-113